1998
DOI: 10.3892/ijo.12.2.245
|View full text |Cite
|
Sign up to set email alerts
|

The predictive role of flow cytometry-derived tumor potential doubling time (Tpot) in radiotherapy: open questions and future perspectives.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0
1

Year Published

2000
2000
2011
2011

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 0 publications
0
6
0
1
Order By: Relevance
“…However, the proposed method may underestimate GF in diploid tumours, if procedures to separate normal cells from tumour cells are not used. The possible solutions to tackle this problem have been summarized by Antognoni P et al [2] and are mainly based on using cytokeratin markers to separate epithelial tumour cells from intratumoural inflammatory cells and fibroblasts. In addition, it is recommended to present cell kinetic data from diploid and aneuploid tumours separately [17].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the proposed method may underestimate GF in diploid tumours, if procedures to separate normal cells from tumour cells are not used. The possible solutions to tackle this problem have been summarized by Antognoni P et al [2] and are mainly based on using cytokeratin markers to separate epithelial tumour cells from intratumoural inflammatory cells and fibroblasts. In addition, it is recommended to present cell kinetic data from diploid and aneuploid tumours separately [17].…”
Section: Discussionmentioning
confidence: 99%
“…T pot is defined as the time to double the number of proliferating cells in the absence of cell loss [1]. This derived cell kinetic parameter has been postulated to be a predictor of a tumour's proliferative capability and has been widely studied in clinic in an attempt to find its prognostic significance and the potential value in predicting treatment outcome [2]. However, more recent evidence has not confirmed the existence of association between T pot and disease outcome measures, whereas information on clinical significance of LI and T S remains ambiguous [3-5].…”
Section: Introductionmentioning
confidence: 99%
“…The procedure is relatively simple: Compute c from equation [5] using the values of and derived from f lu (t), f ld (t), and RM(t). Then apply equations [1], [2], and [3] to obtain T G2ϩM , T S , and T pot .…”
Section: Discussionmentioning
confidence: 99%
“…The calculation of the proliferative parameters of cell populations, particularly the potential doubling time (T pot ), and the durations of DNA synthesis (T S ) and the G2ϩM phases (T G2ϩM ) of the cell cycle is useful in clinical studies (2). These calculations provide insight into cell cycle regulation (14) and the effects of drugs or radiation on cell progression (27,28,29).…”
mentioning
confidence: 99%
“…There are many reasons why SF2 will not predict tumor cure for all patients. Any effects that are due to the tumor environment such as hypoxia (32), angiogenesis (33), tumor immunity (34), or cell cycle distribution (35) will not be predicted by standard SF2 studies. Interestingly, cell cycle effect can be predicted by DNA-EBC analysis.…”
Section: Discussionmentioning
confidence: 99%